Director, Global Access Strategy

ROLE SUMMARY

The Global Access Strategy and Pricing (GASP) Director role directly impacts the ability to achieve business objectives by supporting the development of strategic guidance on access, pricing, optimal reimbursement, launch sequencing, patient value, and evidence generation for Vepdegestrant in preparation for launch and with consideration for subsequent indications. Vepdegestrant is an Alliance product with Arvinas. In collaboration with the Vepdegestrant GASP Lead, the asset development team, and Arvinas partners, the Director will support the development of the market access and pricing strategy, including launch GPA, and support the generation and synthesis of global payer insights, recommendations for clinical trial design for subsequent indications, and development of financial models to evaluate the impact of lifecycle indications and combinations within the Breast cancer portfolio.

This position will function with a 'One Global Access and Value' mindset and work in a closely aligned manner with the the Vepdegestrant GASP Lead, and other GAV colleagues (USMA, HV&E). This role will support the advancement of the integrated value and access strategy (IVAS) in partnership with the cross functional team and Alliance partners, that is aligned to the brand strategy and optimizes the long term value of Vepdegestrant within the context of the breast cancer franchise. The position reports to the GASP Breast Cancer Team Lead within GAV.

ROLE RESPONSIBILITIES

• Lead generation of payer insights and support the translation into clear and cohesive integrated value and access, pricing and evidence generation strategies for key markets to support Vepdegestrant.
• Provide subject matter expertise and support critical strategic discussions at Senior Leadership forums.
• Support Global cross functional and local preparation of Vepdegestrant EU JCA readiness in close partnership with HV&E
• Support shaping breast cancer lifecycle management leveraging expertise in access and price strategies.
• Deliver clear recommendations relating to payer strategy, pricing and reimbursement, evidence generation, data collection and value proposition.
• Participation in virtual cross functional teams including representing GAV at the GPT, and at Alliance meetings. When necessary, coordinate and lead projects related to specific asset threats and opportunities.

Generate & synthesize payer insights

• Maintain in-depth understanding of payer regulations, needs of all types of payers (e.g. HTA agencies, institutions and patients) in key Pfizer markets.
• Knowledgeable about US Oncology Access & Pricing Landscape, IDM Markets, China, HTA/Payer requirements and EU JCA.
• Support assessment and communication of external access trends to anticipate potential challenges and opportunities for Vepdegestrant
• Gather and synthesize feedback for development programs with health technology assessment agencies, payers, and relevant patient associations.

Develop payer value proposition and drive market access strategy

• Support the development of clear and cohesive access, pricing and evidence generation strategy to optimize value of Vepdegestrant .
• Lead discussions with Country Health & Value and Payer Channel Access Leads at critical junctures to ensure local insights are integrated into global plans that optimize long-term value for Vepdegestrant
• Provide input into clinical development plans, market access and pricing strategies and recommendations, early HTA advice, early economic models, and evidence generation plans via the Integrated Value & Access Plan.
• Support alignment efforts with Commercial, BAI, Clinical, Medical, Asset teams, and the Alliance to ensure clinical trial design and commercial strategies reflect payer insights and align with Bold Moves in order to maximize value of Vepdegestrant.
• Support discussions and early buy-in discussions with senior leadership on price and market access strategy and recommendations to support key business decision points.
• Support development of the value proposition and value-based agreement strategy and buy-in from cross-functional stakeholders.
• Develop launch deliverables and deliver training for Pfizer and the Alliance such as Value Story, Objection Handler, Launch Readiness, Mock Negotiations
• Support analyses and recommendations in partnership with the Vepdegestrant GASP Lead and HV&E to influence clinical trial design recommendations (e.g. endpoints, comparators, PROs), development of early economic model, and generation of supplemental evidence (e.g. comparative-effectiveness studies leveraging real-world evidence) to strengthen our value proposition and pricing/access opportunity.

Advance functional excellence in Global Market Access

• Build and maintain relationships with cross-functional teams including HEOR, Medical, Commercial, BAI and others to drive payer perspective and optimize for reimbursability per critical business needs globally for breast cancer.
• Work efficiently and collaboratively in a highly matrixed environment.
• Develop expertise in US, IDM, China markets and launch requirements.

BASIC QUALIFICATIONS

Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.

• Bachelor's degree minimum required.
• 10 years of experience required with Bachelor's; 9 years of experience required with Master's / MBA; 7 years of experience required with PharmD / PhD, preferably in pharmaceutical industry or related consulting services, sufficient to have developed an understanding of the global and US payer and market access environment.
• Experience in developing and executing Pricing & Market Access strategies and deliverables on US and key ex-US markets such as Germany, France, UK, Italy and/or Spain, China, Japan.
• Excellent oral and written English communication skills required

PREFERRED QUALIFICATIONS

• Advanced degree in a healthcare, business or economic field preferred (PH.D, MD or MBA)
• Experience working in beast cancer agents globally, and knowledge of HTA and Payer requirement is desirable. US, IDM, China, country level HTA and negotiation experience is desirable.
• Strong knowledge and understanding of drug development process.
• Pharmaceutical business, including experience in strategy development and interaction with customers.
• Strong project management abilities (contracting, budgeting, vendor management) essential.
• Demonstrated ability to manage multiple projects involving complex processes, significant budget, competing deadlines and rapidly shifting priorities.
• Excellent interpersonal skills required; ability to understand and respond to multiple internal and external customers and influence in a matrix environment.
• Skilled in functioning within a matrix organization where managing through influence is required and experience of managing people in a cross-cultural environment.

Other Job Details:

• Last Date to Apply for Job: August 14th, 2024.
• Eligible for employee referral bonus
• Position is hybrid and will require to work 2 to 3 days per week from site
• Ability to travel depending on business needs

#LI-PFE

The annual base salary for this position ranges from $161,600.00 to $269, In addition, this position is eligible for participation in Pfizer's Global Performance Plan with a bonus target of 20.0% of the base salary and eligibility to participate in our share based long term incentive program. We offer comprehensive and generous benefits and programs to help our colleagues lead healthy lives and to support each of life's moments. Benefits offered include a 401(k) plan with Pfizer Matching Contributions and an additional Pfizer Retirement Savings Contribution, paid vacation, holiday and personal days, paid caregiver/parental and medical leave, and health benefits to include medical, prescription drug, dental and vision coverage. Learn more at Pfizer Candidate Site - U.S. Benefits | ). Pfizer compensation structures and benefit packages are aligned based on the location of hire. The United States salary range provided does not apply to Tampa, FL or any location outside of the United States.

Relocation assistance may be available based on business needs and/or eligibility.

Sunshine Act

Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care provider's name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.

EEO & Employment Eligibility

Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer. This position requires permanent work authorization in the United States.

Market Access